JPET Over 1500 Individual Drug Articles!

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lee, G.
Right arrow Articles by Bendayan, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, G.
Right arrow Articles by Bendayan, R.

Vol. 299, Issue 1, 204-212, October 2001

Functional Expression of P-glycoprotein in Rat Brain Microglia

Gloria Lee, Lyanne Schlichter, Moise Bendayan and Reina Bendayan

Department of Pharmaceutical Sciences, University of Toronto, Toronto, Ontario, Canada (G.L., R.B.); Division of Cellular and Molecular Biology, Toronto Western Research Institute, University Health Network, and Department of Physiology, University of Toronto, Toronto, Ontario, Canada (L.S.); and Département de Pathologie et Biologie Cellulaire, Université de Montréal, Montréal, Québec, Canada (M.B.)

In the central nervous system, the primary targets of the human immunodeficiency virus-1 (HIV-1) are microglia, resulting in a disorder called HIV-1 dementia. P-glycoprotein (P-gp), a membrane-associated ATP-dependent efflux transporter, limits entry into the brain of numerous xenobiotics, including anti-HIV drugs (i.e., protease inhibitors). This project investigates the functional expression of P-gp in the endogenous immune cells of the brain, a parenchymal compartment not previously studied. We used a cell line (MLS-9) derived from rat microglia to study the transport of digoxin, a known P-gp substrate. Reverse transcriptase-polymerase chain reaction analysis detected mRNA for only mdr1b in MLS-9 cells, whereas both mdr1a and mdr1b mRNA were expressed in primary cultured microglia from which they were derived. Western blot analysis with the C219 antibody detected a single band at ~170 to 180 kDa in MLS-9 cells, which is the size previously reported for P-gp. Immunocytochemical analysis with the monoclonal antibodies C219, MRK16, and MAB-448 labeled P-gp protein along the plasma membrane and nuclear envelope of MLS-9 cells. [3H]Digoxin accumulation by monolayers of MLS-9 cells was significantly enhanced in the presence of any of several P-gp inhibitors (verapamil, cyclosporin A, quinidine, PSC 833), protease inhibitors (i.e., saquinavir, indinavir, and ritonavir), and sodium azide, an ATPase inhibitor. These results provide the first evidence for the functional expression of P-gp in microglia and imply that entry of pharmacological agents, including protease inhibitors, may be prevented within the brain parenchyma, as well as at the blood-brain barrier.

0022-3565/01/2991-0204$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2001 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 J. Histochem. Cytochem.Home page
R. Bendayan, P. T. Ronaldson, D. Gingras, and M. Bendayan
In Situ Localization of P-glycoprotein (ABCB1) in Human and Rat Brain
J. Histochem. Cytochem., October 1, 2006; 54(10): 1159 - 1167.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
P. T. Ronaldson and R. Bendayan
HIV-1 Viral Envelope Glycoprotein gp120 Triggers an Inflammatory Response in Cultured Rat Astrocytes and Regulates the Functional Expression of P-Glycoprotein
Mol. Pharmacol., September 1, 2006; 70(3): 1087 - 1098.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
S. Dallas, D. S. Miller, and R. Bendayan
Multidrug resistance-associated proteins: expression and function in the central nervous system.
Pharmacol. Rev., June 1, 2006; 58(2): 140 - 161.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
F. Bourasset, K. Bernard, C. Munoz, P. Genissel, and J.-M. Scherrmann
NEUROPHARMACOKINETICS OF A NEW {alpha}-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLE PROPIONIC ACID (AMPA) MODULATOR, S18986 [(S)-2,3-DIHYDRO-[3,4]CYCLOPENTANO-1,2,4-BENZOTHIADIAZINE-1,1-DIOXIDE], IN THE RAT
Drug Metab. Dispos., August 1, 2005; 33(8): 1137 - 1143.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
S. Dallas, L. Schlichter, and R. Bendayan
Multidrug Resistance Protein (MRP) 4- and MRP 5-Mediated Efflux of 9-(2-Phosphonylmethoxyethyl)adenine by Microglia
J. Pharmacol. Exp. Ther., June 1, 2004; 309(3): 1221 - 1229.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
S. Dallas, X. Zhu, S. Baruchel, L. Schlichter, and R. Bendayan
Functional Expression of the Multidrug Resistance Protein 1 in Microglia
J. Pharmacol. Exp. Ther., October 1, 2003; 307(1): 282 - 290.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
F. Imbert, M. Jardin, C. Fernandez, J. C. Gantier, F. Dromer, G. Baron, F. Mentre, L. van Beijsterveldt, E. Singlas, and F. Gimenez
Effect of Efflux Inhibition on Brain Uptake of Itraconazole in Mice Infected with Cryptococcus neoformans
Drug Metab. Dispos., March 1, 2003; 31(3): 319 - 325.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
G. Lee, S. Dallas, M. Hong, and R. Bendayan
Drug Transporters in the Central Nervous System: Brain Barriers and Brain Parenchyma Considerations
Pharmacol. Rev., December 1, 2001; 53(4): 569 - 596.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 2001 by the American Society for Pharmacology and Experimental Therapeutics.